Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
about
Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopeniaEfficacy of a fish protein hydrolysate in malnourished childrenResponse: arguments contradict the "foreign protein-zidovudine" hypothesisComparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia AViral and latent reservoir persistence in HIV-1-infected patients on therapyModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsCD4 immunophenotyping in HIV infection.Exclusion-Based Capture and Enumeration of CD4+ T Cells from Whole Blood for Low-Resource Settings.Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-needEstablishing the reference range for T lymphocytes subpopulations in adults and children from Brazil.Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Establishment of Normal Reference Intervals for CD3(+), CD4(+), CD8(+), and CD4(+) to CD8(+) Ratio of T Lymphocytes in HIV Negative Adults from University of Gondar Hospital, North West Ethiopia.Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patientsA review on peripheral blood CD4+ T lymphocyte counts in healthy adult IndiansPredictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model.Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study GroupEstablishment of reference CD4+ T cell values for adult Indian population.Population-based hematologic and immunologic reference values for a healthy Ugandan population.Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionThe significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversionCategory of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study GroupIdiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells.Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settingsPrecise determination of time to reach viral load set point after acute HIV-1 infection.Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.Immune function in Amazonian horticulturalists.Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto.Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.Dynamics analysis and simulation of a modified HIV infection model with a saturated infection rate.CD4 counting technologies for HIV therapy monitoring in resource-poor settings--state-of-the-art and emerging microtechnologies.Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.Ultrasensitive Analysis of Binding Affinity of HIV Receptor and Neutralizing Antibody Using Solution-Phase Electrochemiluminescence Assay.An HIV model with age-structured latently infected cells.
P2860
Q24562743-3ED7E811-6931-40F4-AC3D-79ADCE8AE54AQ24630814-3E287C38-711A-4066-940F-2BB52F5AD6B7Q24655637-E9AB501A-A260-4B0A-B9F6-8125F206DD60Q24655670-79D66984-C980-4B64-9F11-E1DDB9D23C8DQ28469057-37D55FE0-43E5-4642-8B0B-5214569A9148Q28551803-B0A0ACAC-37CA-4C6F-AD3F-32F75A58DB4DQ30372724-5F7A83FF-4112-49C0-B141-A35474B3E13EQ30616783-C7979B70-004D-4670-B525-D6B0F7F93A22Q33761262-0C15355D-4F7D-471A-998B-92C785C72211Q33926456-27DBDEE2-9A28-4964-9975-DEE9E95516E4Q33935910-9CE4167B-3BE0-446D-ABC1-F88210EB02F3Q33944474-29D5CAF3-6E7E-4369-99B4-A02D2628EC3AQ34405742-05EC2CFD-F900-461E-AC69-16C632A90385Q34610003-97C0145B-E979-4164-82C4-5620FFB9FA0EQ34657787-D88AEA7F-16F1-4D8C-8479-8FBB368AD4C8Q34765992-CC1A7254-FDBE-44BF-8C93-0F609D870237Q35008567-E45C32F6-3319-4A23-9ECB-6FACC8E6AAF9Q35035472-1C8EDE93-0D96-4AD0-BDDB-255E15F025A9Q35118830-488A304C-045C-4F6F-9F3B-E012C6E719F8Q35224739-AC79FFEC-E0FF-45E4-94AB-1B058DD6A524Q35415301-88491E50-0148-4FD8-8DFC-1186089D72A5Q35542336-A447EE93-432E-4DF0-9BD6-362995CECCA9Q36066494-033A1400-18F5-4877-A25D-2DDFF3E92ED5Q36362035-9B492DE1-A767-4F31-94FB-365391DD9CE5Q36503545-4C0F5897-581A-4754-93C9-3F1D3B229114Q36600140-6FA873D9-1478-4106-924C-0EF24957F14DQ36633448-F245D38D-6679-407B-9024-C0A79912DF2EQ36854142-7BC7A809-C58C-4711-919F-126E9341710DQ36877987-C7ED5720-0E73-49D0-B3B4-83FC0D232D1AQ36995136-C47DFA1D-AE25-4AFE-A258-0A831292B9CEQ37133236-BA15F860-6B5E-4686-8EB9-DD4963D8DCD5Q37156722-517D43F1-18B0-4C01-BEA4-7DFB5295EE04Q37435114-27DD2F61-8E1D-436B-B82A-FD6B9E140E05Q37489326-4483FEBF-DF19-4355-B6DB-03C7A1B04320Q37499490-D7B841D6-18B4-4524-A9AD-EF3349C4DDD3Q37693905-5ED49BE0-3637-4256-A291-2139512260EAQ38106615-0E0ED941-687A-487D-9021-11017B0E7429Q38917930-E9596D73-C4CD-41DD-9EC9-E35A54602F40Q39584052-37F2A8C2-5AE1-421C-BF12-C209065F6843Q40638814-B7F017EB-590B-45E2-8D6A-1A4B85AA1D7B
P2860
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@ast
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@en
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@nl
type
label
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@ast
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@en
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@nl
prefLabel
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@ast
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@en
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@nl
P2093
P2860
P1476
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
@en
P2093
A N Phillips
D MacDonald-Burns
M A Johnson
P B Kernoff
P2860
P304
P356
10.1111/J.1365-2249.1992.TB03068.X
P407
P577
1992-05-01T00:00:00Z